Fibroblast Growth Factor Receptor Inhibitors [MoA] - N0000194026
Pharmacologic Class Information
| Pharmacologic Code | N0000194026 |
| Pharmacologic Name | Fibroblast Growth Factor Receptor Inhibitors |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Mechanisms of Action - [MoA] |
| Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Fibroblast Growth Factor Receptor Inhibitors
The table contains 3 products whose active ingredient are classified under the same pharmacologic class Fibroblast Growth Factor Receptor Inhibitors [MoA].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 59676-030 | Balversa | Non-Proprietary Name: Erdafitinib | Tablet, Film Coated | Oral | Janssen Products Lp | ACTIVE | |
| 59676-040 | Balversa | Non-Proprietary Name: Erdafitinib | Tablet, Film Coated | Oral | Janssen Products Lp | ACTIVE | |
| 59676-050 | Balversa | Non-Proprietary Name: Erdafitinib | Tablet, Film Coated | Oral | Janssen Products Lp | ACTIVE |